Pharmacological properties of TRK-820 on cloned μ-, δ- and κ-opioid receptors and nociceptin receptor
- 12 July 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 376 (1-2) , 159-167
- https://doi.org/10.1016/s0014-2999(99)00369-6
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- ORL1, a novel member of the opioid receptor familyPublished by Wiley ,2001
- [Phe1Ψ(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cordNeuroscience Letters, 1998
- Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioidsFEBS Letters, 1996
- Opioid AnalgesicsDrugs, 1996
- Pharmacological study of dihydroetorphine in cloned μ-, δ- and κ-opioid receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- cDNA cloning and regional distribution of a novel member of the opioid receptor familyFEBS Letters, 1994
- Cloning and expression of a cDNA for the rat k‐opioid receptorFEBS Letters, 1993
- Primary structures and expression from cDNAs of rat opioid receptor δ‐and μ‐subtypesFEBS Letters, 1993
- U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouseLife Sciences, 1982
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973